首页> 外文会议>IEEE International Conference on Computational Advances in Bio and Medical Sciences >Poster: Classifying primary outcomes in rheumatoid arthritis: Knowledge discovery from clinical trial metadata
【24h】

Poster: Classifying primary outcomes in rheumatoid arthritis: Knowledge discovery from clinical trial metadata

机译:海报:对类风湿关节炎的主要结局进行分类:从临床试验元数据中发现知识

获取原文

摘要

Early prediction of treatment outcomes in RA clinical trials is critical for both patient safety and trial success. We hypothesize that an approach employing metadata of clinical trials could provide accurate classification of primary outcomes before trial implementation. We retrieved RA clinical trials metadata from ClinicalTrials.gov. Four quantitative outcome measures that are frequently used in RA trials, i.e., ACR20, DAS28, and AE/SAE, were the classification targets in the model. Classification rules were applied to make the prediction and were evaluated. The results confirmed our hypothesis. We concluded that the metadata in clinical trials could be used to make early prediction of the study outcomes with acceptable accuracy.
机译:RA临床试验中对治疗结果的早期预测对于患者安全和试验成功均至关重要。我们假设采用临床试验元数据的方法可以在试验实施之前对主要结果进行准确分类。我们从ClinicalTrials.gov检索了RA临床试验元数据。模型试验的分类目标是RA试验中经常使用的四种定量结果指标,即ACR20,DAS28和AE / SAE。应用分类规则进行预测并进行评估。结果证实了我们的假设。我们得出的结论是,临床试验中的元数据可用于以可接受的准确性对研究结果进行早期预测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号